Treatment-related toxicity
| . | Arm A (n = 97) . | Arm B (n = 98) . | P . |
|---|---|---|---|
| First autologous transplant | |||
| Patients, no. (%) | 87 (90) | 85 (87) | NS |
| Median duration of neutropenia,* days (range) | 8 (4–12) | 8 (5–13) | NS |
| Median duration of thrombocytopenia,† days (range) | 9 (2–19) | 10 (2–20) | NS |
| Platelet transfusions, no. (range) | 4 (0–10) | 3 (0–11) | NS |
| Treatment-related deaths, no. | 2 | 1 | NS |
| Second autologous transplant | |||
| Patients, no. (%) | 80 (82) | 9 (9) | NA |
| Median duration of neutropenia,* days (range) | 9 (4–14) | 10 (6–14) | NS |
| Median duration of thrombocytopenia,† days (range) | 12 (4–22) | 13 (6–23) | NS |
| Platelet transfusions, no. (range) | 5 (1–12) | 5 (1–11) | NS |
| Treatment-related deaths, no. | 2 | 1 | NS |
| . | Arm A (n = 97) . | Arm B (n = 98) . | P . |
|---|---|---|---|
| First autologous transplant | |||
| Patients, no. (%) | 87 (90) | 85 (87) | NS |
| Median duration of neutropenia,* days (range) | 8 (4–12) | 8 (5–13) | NS |
| Median duration of thrombocytopenia,† days (range) | 9 (2–19) | 10 (2–20) | NS |
| Platelet transfusions, no. (range) | 4 (0–10) | 3 (0–11) | NS |
| Treatment-related deaths, no. | 2 | 1 | NS |
| Second autologous transplant | |||
| Patients, no. (%) | 80 (82) | 9 (9) | NA |
| Median duration of neutropenia,* days (range) | 9 (4–14) | 10 (6–14) | NS |
| Median duration of thrombocytopenia,† days (range) | 12 (4–22) | 13 (6–23) | NS |
| Platelet transfusions, no. (range) | 5 (1–12) | 5 (1–11) | NS |
| Treatment-related deaths, no. | 2 | 1 | NS |